Skip to content

The impact of exogenous albumin infusion on prognosis in ICU patients with different albumin levels (< 30 g/L and < 35 g/L)

The impact of exogenous albumin infusion on prognosis in ICU patients with different albumin levels (< 30 g/L and < 35 g/L)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122877
Enrollment
Unknown
Registered
2026-04-20
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple organ failure

Interventions

Observation group:None

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.Hospitalized in the ICU from January 1, 2022 to December 31, 2025; 3.During the stay in the ICU, there was at least one instance where the serum albumin test value was lower than 35g/L (to determine the potential eligibility for the study intervention); 4.When the albumin level was first detected to be below 35g/L, albumin infusion had not yet been administered.

Exclusion criteria

Exclusion criteria: 1.The patient was admitted to the ICU for less than 24 hours. 2.During the hospitalization in the ICU, key variables (such as daily albumin levels and SOFA score) were not recorded. 3.Pregnant women or women who are breastfeeding; 4.Expected survival time for end-stage disease is less than 24 hours; 5.Has a history of allergy to albumin before.

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Secondary

MeasureTime frame
Length of stay in the ICU;The number of days without organ support within 28 days;Duration of mechanical ventilation;

Countries

China

Contacts

Public ContactHu Jie

Huzhou Center Hospital

1022637645@qq.com+86 13454282937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026